FDA OKs new drug for heavy periods

updated 4:36 p.m. ET Nov. 13, 2009

WASHINGTON - Federal health officials have approved a new drug as the first non-hormonal treatment for heavy menstrual bleeding.

The Food and Drug Administration says Lysteda tablets reduce bleeding by acting on a protein that helps blood clot. The drug is made by Newport, Ky.-based Xanodyne Pharmaceuticals.

The main ingredient in the drug was first approved in 1986 as an injection for patients with hemophilia, an inheritable disease that prevents blood clotting.

The FDA warns that taking Lysteda with hormonal contraceptive drugs can increase the risk of blood clots, stroke and heart attacks. Women should only use the products together if there is a strong medical need, the agency says.

Also in msnbc.com Health When gifts seem to say: You're old, fat and hairy Air ambulances leave some with sky-high bills Docs airlift toddler with 42 needles stuck in him Looks buy happiness, but only in the city | Poll   Animal Tracks: Eye candy for animal lovers

MORE FROM WOMEN'S HEALTH

Women's health Section Front

NYT: Building a baby, with few ground rules NYT: Menopause, as brought to you by drug makers Study finds benefits of soy after breast cancer Breastfeeding may curb heart, diabetes risk More women choose do-it-yourself births Are you having an affair ... with your baby? Show your bod some thanks, inside and out NYT: Health bill revives abortion groups New guidelines: Pap smears can start at 21 Mammogram advice accurate but not ‘right’ Women's health Section Front   Add Women's health headlines to your news reader: